| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 91 |
| 1 | PREDNISONE | 84 |
| 2 | ATOVAQUONE | 61 |
| 3 | ATOVAQUONE ORAL SUSPENSION | 56 |
| 4 | CYCLOPHOSPHAMIDE | 40 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 40 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 40 |
| 7 | AZITHROMYCIN | 38 |
| 8 | AZITHROMYCIN DIHYDRATE | 38 |
| 9 | AZITHROMYCIN MONOHYDRATE | 38 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAFENOQUINE | 5 | 0.0758 |
| 1 | NATURAL VEGETABLE LAXATIVE | 1 | 0.0244 |
| 2 | UNCARIA TOMENTOSA | 1 | 0.0082 |
| 3 | ATOVAQUONE | 61 | 0.0074 |
| 4 | ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL | 1 | 0.0064 |
| 5 | ARTEMETHER AND LUMEFANTRINE | 1 | 0.0051 |
| 6 | INOTUZUMAB OZOGAMICIN | 15 | 0.0050 |
| 7 | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | 7 | 0.0033 |
| 8 | ANDEXANET ALFA | 1 | 0.0014 |
| 9 | BLINATUMOMAB | 15 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 116 |
| 1 | Corticosteroid [EPC] | 98 |
| 2 | Antimalarial [EPC] | 62 |
| 3 | Antiprotozoal [EPC] | 61 |
| 4 | Alkylating Drug [EPC] | 40 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 25 |
| 6 | Kinase Inhibitor [EPC] | 21 |
| 7 | Tetracycline-class Drug [EPC] | 20 |
| 8 | Benzodiazepine [EPC] | 16 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimalarial [EPC] | 62 | 0.0059 |
| 1 | Antiprotozoal [EPC] | 61 | 0.0057 |
| 2 | CD22-directed Immunoconjugate [EPC] | 15 | 0.0050 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 116 | 0.0004 |
| 4 | Tetracycline-class Drug [EPC] | 20 | 0.0003 |
| 5 | Human Immunoglobulin G [EPC] | 5 | 0.0002 |
| 6 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 7 | Antiparasitic [EPC] | 1 | 0.0002 |
| 8 | Pediculicide [EPC] | 1 | 0.0002 |
| 9 | Sulfone [EPC] | 2 | 0.0002 |